David Fater, Chief Executive Officer of Vicor Technologies, Inc. will be presenting at Life Tech Capital’s First Annual Miami Medical Investors Conference on November 12, 2010. LifeTech Capital is a multi-disciplinary team of investment professionals which specialize in serving the biotechnology, medical technology, and life technology industries and investment community. Mr. Fater will be speaking at 9:30 AM EST in Presentation Room #2. The event will be held in Miami, FL at the JW Marriot Marquis Miami.
Mr. Fater will be describing Vicor’s unique PD2i® nonlinear algorithm and accompanying software as well as the Company’s business strategy. Vicor is emerging as a leading biotech company engaged in developing innovative, non-invasive medical devices using the patented PD2i technology. Presently, Vicor is in the process of commercializing diagnostics that assist physicians in accurate risk stratification of specific target populations for future pathological events. While many applications are possible with the PD2i Analyzer, Vicor is currently focused on cardiovascular disease patients with risk of death from arrhythmia or pump failure, diabetics for diabetic autonomic neuropathy and trauma victims for imminent death absent life-saving intervention.
More on Vicor Technologies and the PD2i algorithm can be found on the Company’s website at www.vicortech.com.
No comments:
Post a Comment